Bimatoprost Ophthalmic Solution 0.03% w/v – Maxlash 3 mL is an ophthalmic medicine containing bimatoprost, a prostaglandin analogue. Bimatoprost ophthalmic solution 0.03% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Maxlash 3 mL is offered for pharmaceutical sourcing and international medicine-export inquiries, subject to product availability and the regulatory requirements of the destination market.
Product Information
Product: Maxlash
Composition: Bimatoprost
Strength: 0.03% w/v
Dosage Form: Ophthalmic Solution
Pack Size: 3 mL
Therapeutic Area: Ophthalmology
Active Ingredient: Bimatoprost
Route: Topical ophthalmic administration
Bimatoprost 0.03% Uses
Bimatoprost ophthalmic solution 0.03% is used to reduce elevated intraocular pressure associated with open-angle glaucoma and ocular hypertension.
The product should be used only according to the approved prescribing information and under appropriate medical supervision.
Key Product Features
- Bimatoprost 0.03% ophthalmic formulation
- Convenient 3 mL presentation
- Ophthalmology-focused pharmaceutical product
- Suitable for international sourcing inquiries
- Professional export and supply assistance
- Destination-specific regulatory requirements can be reviewed before shipment
Dosage Information
The labeled dosage for bimatoprost ophthalmic solution 0.03% is generally one drop in the affected eye(s) once daily in the evening. More frequent administration is not recommended because it may reduce the intraocular-pressure-lowering effect.
Patients should follow the prescribing instructions provided for their specific product and market.
Safety & Important Considerations
Bimatoprost may cause conjunctival hyperemia, eyelash changes, and pigmentation of the iris, eyelid, or surrounding tissue. Iris pigmentation may be permanent, while eyelash changes are generally reversible after discontinuation.
Hypersensitivity to bimatoprost or any component of the formulation is a contraindication.
This product is intended for appropriate pharmaceutical use and should not be self-administered without professional medical advice.
International Bimatoprost Export & Supply
MEDINDIA EXPORT supports international pharmaceutical sourcing and medicine-export inquiries for buyers, distributors, pharmacies, healthcare businesses, and other eligible purchasers.
Target Markets
USA | UK | Singapore | Thailand | UAE | Australia | Malaysia | New Zealand | Canada | South Africa | Germany | France | Italy | Spain | Netherlands | Ireland | Sweden | Norway | Denmark | Finland | Belgium | Austria | Switzerland | Poland | Portugal | Greece
Availability and import requirements can differ between countries. Buyers are responsible for ensuring compliance with the applicable laws, prescription requirements, import permissions, and pharmaceutical regulations in their destination market.
Why Choose MEDINDIA EXPORT?
- International medicine-export support
- Pharmaceutical product sourcing
- Worldwide shipping assistance
- Destination-specific inquiry support
- Professional quotation assistance
- Support for bulk and commercial requirements
- Multiple therapeutic categories available
- International buyer and distributor support
Trading FAQs
What is Maxlash 3 mL?
Maxlash 3 mL is a bimatoprost ophthalmic solution containing 0.03% w/v bimatoprost.
What is Bimatoprost 0.03% used for?
Bimatoprost ophthalmic solution 0.03% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
What is the pack size?
The requested presentation is a 3 mL ophthalmic solution.
How should Bimatoprost ophthalmic solution be used?
The labeled regimen for bimatoprost ophthalmic solution 0.03% is generally one drop in the affected eye(s) once daily in the evening. Patients should follow the instructions applicable to their specific product.
Can Maxlash be exported internationally?
International supply is subject to product availability, destination-country regulations, import requirements, and applicable pharmaceutical laws.
Can I request a quotation?
Yes. Send the product name, required quantity, destination country, and shipping details to our sales team for an availability and quotation inquiry.
Is Bimatoprost a prescription medicine?
Bimatoprost ophthalmic solution is a prescription medicine in jurisdictions including the United States. Regulatory classification can vary by country.
Does Bimatoprost have side effects?
Potential effects include conjunctival hyperemia, eyelash changes, and pigmentation changes around the eye. Consult a qualified healthcare professional for product-specific safety information.
Request Bimatoprost 0.03% Supply
For Maxlash Bimatoprost Ophthalmic Solution 0.03% w/v – 3 mL availability, pricing, and international pharmaceutical sourcing:
🌐 Website: www.medicineindiaexport.com
📧 Email: sales.medindiaexport@gmail.com
📱 WhatsApp: +91 7218129896
MEDINDIA EXPORT – International Medicine Export & Pharmaceutical Sourcing